| Healthcare and Medical Technology |
1 |
1 |
| Lung |
0 |
0.99 |
| Asthma |
0 |
0.87 |
| Lung Fibrosis |
0 |
0.68 |
| Small Cell Lung Cancer |
0 |
0.57 |
| Idiopathic Pulmonary Fibrosis |
0 |
0.98 |
| Toxicology |
0 |
0.47 |
| Tissue |
0 |
0.36 |
| Lung Cancer |
0 |
0.35 |
| Stem Cell Research and Therapy |
0 |
0.29 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.28 |
| COVID-19 |
0 |
0.23 |
| Drug Development |
0 |
0.11 |
| Clinical Research |
0 |
0.09 |
| Airway |
0 |
0.07 |
| Cystic Fibrosis |
0 |
0.07 |
| Influenza |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |
| Wound Management |
0 |
0.07 |
| Cancer |
0 |
0.06 |
| Tumor |
0 |
0.06 |
| Bone Marrow |
0 |
0.05 |
| Alabama |
0 |
0.04 |
| Animal Research |
0 |
0.04 |
| Biomarker |
0 |
0.04 |
| Biopsy |
0 |
0.04 |
| Blood |
0 |
0.04 |
| Blood Vessel |
0 |
0.04 |
| Bone |
0 |
0.04 |
| Brain |
0 |
0.04 |
| Bronchoconstriction |
0 |
0.04 |
| Immunocompromise |
0 |
0.04 |
| Pulmonary Edema |
0 |
0.03 |
| Thoracic Surgery |
0 |
0.03 |
| Bacteria |
0 |
0.02 |
| Capillary |
0 |
0.02 |
| Cytokines |
0 |
0.02 |
| Edema |
0 |
0.02 |
| Environmental Medicine |
0 |
0.02 |
| Epithelium |
0 |
0.02 |
| Europe |
0 |
0.02 |
| Health Care Economics |
0 |
0.02 |
| Injury |
0 |
0.02 |
| Investment |
0 |
0.02 |
| Liver |
0 |
0.02 |
| Pathogenesis |
0 |
0.02 |
| Pennsylvania |
0 |
0.02 |
| Preventive Screening |
0 |
0.02 |
| Students |
0 |
0.02 |
| Surgery |
0 |
0.02 |
| Viral Infection |
0 |
0.02 |